Yates AJ - Search Results

1

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial.

Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA, Palermo L, Prineas R, Rubin SM, Scott JC, Vogt T, Wallace R, Yates AJ, LaCroix AZ. Cummings SR, et al. Among authors: yates aj. JAMA. 1998 Dec 23-30;280(24):2077-82. doi: 10.1001/jama.280.24.2077. JAMA. 1998. PMID: 9875874 Clinical Trial.

2

Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures. Fracture Intervention Trial Research Group.

Nevitt MC, Thompson DE, Black DM, Rubin SR, Ensrud K, Yates AJ, Cummings SR. Nevitt MC, et al. Among authors: yates aj. Arch Intern Med. 2000 Jan 10;160(1):77-85. doi: 10.1001/archinte.160.1.77. Arch Intern Med. 2000. PMID: 10632308 Clinical Trial.

3

Skeletal benefits of two years of alendronate treatment are similar for early postmenopausal Asian and Caucasian women.

Wasnich RD, Ross PD, Thompson DE, Cizza G, Yates AJ. Wasnich RD, et al. Among authors: yates aj. Osteoporos Int. 1999;9(5):455-60. doi: 10.1007/s001980050171. Osteoporos Int. 1999. PMID: 10550466 Clinical Trial.

4

Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: a randomized, placebo-controlled trial.

Reid IR, Nicholson GC, Weinstein RS, Hosking DJ, Cundy T, Kotowicz MA, Murphy WA Jr, Yeap S, Dufresne S, Lombardi A, Musliner TA, Thompson DE, Yates AJ. Reid IR, et al. Among authors: yates aj. Am J Med. 1996 Oct;101(4):341-8. doi: 10.1016/s0002-9343(96)00227-6. Am J Med. 1996. PMID: 8873503 Clinical Trial.

5

Monitoring of alendronate treatment and prediction of effect on bone mass by biochemical markers in the early postmenopausal intervention cohort study.

Ravn P, Hosking D, Thompson D, Cizza G, Wasnich RD, McClung M, Yates AJ, Bjarnason NH, Christiansen C. Ravn P, et al. Among authors: yates aj. J Clin Endocrinol Metab. 1999 Jul;84(7):2363-8. doi: 10.1210/jcem.84.7.5847. J Clin Endocrinol Metab. 1999. PMID: 10404804 Clinical Trial.

6

Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group.

Ravn P, Cizza G, Bjarnason NH, Thompson D, Daley M, Wasnich RD, McClung M, Hosking D, Yates AJ, Christiansen C. Ravn P, et al. Among authors: yates aj. J Bone Miner Res. 1999 Sep;14(9):1622-7. doi: 10.1359/jbmr.1999.14.9.1622. J Bone Miner Res. 1999. PMID: 10469292 Free article. Clinical Trial.

7

Evidence that increased calcium intake does not prevent early postmenopausal bone loss.

Hosking DJ, Ross PD, Thompson DE, Wasnich RD, McClung M, Bjarnason NH, Ravn P, Cizza G, Daley M, Yates AJ. Hosking DJ, et al. Among authors: yates aj. Clin Ther. 1998 Sep-Oct;20(5):933-44. doi: 10.1016/s0149-2918(98)80075-1. Clin Ther. 1998. PMID: 9829445 Clinical Trial.

8

Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen Study Group.

Bone HG, Greenspan SL, McKeever C, Bell N, Davidson M, Downs RW, Emkey R, Meunier PJ, Miller SS, Mulloy AL, Recker RR, Weiss SR, Heyden N, Musliner T, Suryawanshi S, Yates AJ, Lombardi A. Bone HG, et al. Among authors: yates aj. J Clin Endocrinol Metab. 2000 Feb;85(2):720-6. doi: 10.1210/jcem.85.2.6393. J Clin Endocrinol Metab. 2000. PMID: 10690882 Clinical Trial.

9

Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.

Hosking D, Chilvers CE, Christiansen C, Ravn P, Wasnich R, Ross P, McClung M, Balske A, Thompson D, Daley M, Yates AJ. Hosking D, et al. Among authors: yates aj. N Engl J Med. 1998 Feb 19;338(8):485-92. doi: 10.1056/NEJM199802193380801. N Engl J Med. 1998. PMID: 9443925 Free article. Clinical Trial.

10

Body size accounts for most differences in bone density between Asian and Caucasian women. The EPIC (Early Postmenopausal Interventional Cohort) Study Group.

Ross PD, He Y, Yates AJ, Coupland C, Ravn P, McClung M, Thompson D, Wasnich RD. Ross PD, et al. Among authors: yates aj. Calcif Tissue Int. 1996 Nov;59(5):339-43. doi: 10.1007/s002239900137. Calcif Tissue Int. 1996. PMID: 8849399

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

357 results

Search Page